1136-81 Epsilon Protein Kinase C (PKC) Activation by Delta PKC in Ethanol-Induced Cardiac Protection From Ischemia
Koichi Inagaki, Daria Mochly-Rosen, Stanford University School of Medicine, Stanford, CA
Background: Previous studies have demonstrated that acute ethanol exposure induces activation of δ Protein kinase C (PKC) and εPKC, and mimics ischemic preconditioning via εPKC activation. However, the role of εPKC isozyme in ischemia/reperfusion is still controversial. Here, we investigated the role of δPKC in ethanol-induced cardioprotection using a δPKC-selective activator (ψδRACK), a selective inhibitor (δV1-1), and an εPKCselective inhibitor (εV1-2) in isolated mouse hearts. Methods: Mice were injected intraperitoneally with 0.5g/kg of ethanol or ψδRACK, and saline, δV1-1 or εV1-2 before ischemia. Mouse hearts were then subjected to a 30minute global ischemia and a 120-minute reperfusion, ex vivo. Results: Ethanol treatment 60 minutes, but not 10 minutes, before ischemia reduced infarct size and CPK release. Pretreatment with εV1-2 completely inhibited ethanol-induced cardioprotection. Pretreatment with δV1-1 induced cardioprotection when mice were injected with ethanol 10 minutes before ischemia, but δV1-1 partly inhibited ethanolinduced cardioprotection when mice were injected with ethanol 60 minutes before ischemia. ψδRACK injection 60 minutes, but not 10 minutes, before ischemia induced cardioprotection and this cardioprotection was completely inhibited by pretreatment with εV1-2. Furthermore, ψδRACK induced the translocation of εPKC from the cytosol to the particulate fraction 60 minutes, but not 10 minutes, before ischemia, in vivo. However, in isolated cardiomyocytes, ψRACK treatment did not induce translocation of εPKC. Conclusions: Treatment with ethanol (0.5g/kg) or δPKC activator induces cardioprotection against ischemia/reperfusion one hour, but not immediately before ischemia. Ethanol-induced δPKC activation confers cardioprotection via εPKC activation one hour after treatment. δPKC-induced εPKC activation may be mediated by soluble factors released from non-cardiomyocytes.
1136-82 Tetrahydrobiopterin Depletion Leads to Endothelial Nitric Oxide Synthase Dysfunction in Ischemic Hearts
Yong Xia, Roberto Biondi, Tiebaud Liebgott, Nazareno Paolocci, AJ Cardounel, Giuseppe Ambrosio, Jay L. Zweier, University of Perugia School of Medicine, Perugia, Italy, Johns Hopkins School of Medicine, Baltimore, MD Background: Endothelial nitric oxide synthase (eNOS) function is impaired in ischemic hearts. However, the mechanism of this impairment is unclear. eNOS activity requires availability of cofactors such as tetrahydrobiopterin (BH4). It has been shown that lack of BH4 contributes to eNOS dysfunction in hypercholesterolemia and hypertension. Yet, whether decreased BH4 is involved in ischemia-induced eNOS dysfunction is unclear. Methods: We evaluated changes in BH4 content and eNOS activity in rat hearts subjected to 30, 45 or 60 min global ischemia at 37°C. BH4 content was measured on cardiac homogenate by HPLC using electrochemical detection; eNOS activity was assayed by L-[14C] arginine to L-[14C] citrulline conversion. Results: Ischemia led to a dramatic decrease in BH4 content within 30 min; this loss was paralleled by a substantial and progressive reduction in eNOS activity (Table) . To investigate whether decreased eNOS activity was causally related to BH4 depletion, in parallel experiments eNOS activity was measured in presence of an excess (10 µM) exogenous BH4. BH4 addition substantially restored eNOS activity when ischemia was limited to 30 min (Table) ; no increase in eNOS activity was observed in presence of BH4 after longer time of ischemia (45 and 60 min). Conclusions: Our data show that ischemia induces a major loss in cardiac BH4 content, and that eNOS activity is critically anchored to BH4 bioavailability in this setting. Supplementation with exogenous BH4 may partially restore eNOS function
1136-83 Simulated Ischemia/Reperfusion Promotes Akt Phosphorylation via Both Redox-Sensitive and Insensitive Mechanisms in H9c2 Cells
Tai-Hwang M. Fan, Zhe Jiao, Emory University/Atlanta VA Medical Center, Atlanta, GA Background: Akt is a serine/threonine kinase that has been shown to play key regulatory roles in many physiological processes including glucose metabolism, cell proliferation and migration, and cell survival against apoptosis. The paradigm for activation of Akt involves phosphatidylinositol 3-kinase (PI3K)-dependent membrane localization followed by phosphorylation of two critical residues, Ser473 near the carboxyl terminus and Thr308 in the activation loop. In this study, we examined the effects of simulated ischemia/reperfusion (I/R) on Akt in cardiac cells. We hypothesized that reactive oxygen species production during reperfusion is a prerequisite for phosphorylation to occur at each of the two phosphorylation sites. Methods: H9c2 cells, derived from embryonic heart tissue, were used for the study. Simulated ischemia was induced by incubating the cells in an "ischemic medium" placed in an air-tight anaerobic chamber purged with 95%N 2 /5% CO 2 . Following 3 hr of "ischemia," cells were "reperfused" with maintenance culture medium for 1 hr. Site-specific Akt phosphorylation was evaluated by Western analysis using phospho-specific antibodies against Ser473 phospho-Akt and Thr308 phospho-Akt. Results: Ischemia alone induced a selective decrease in Ser473 phospho-Akt levels (58% reduction compared to normoxic controls, p<0.05) without affecting Thr308 phosphorylation. Reperfusion caused both Ser473 and Thr308 phospho-Akt levels to increase without affecting total Akt levels. The effect of I/R on Ser473 phosphorylation and Thr308 phosphorylation was completely blocked by pretreatment of the cells with the PI3K inhibitor wortmannin (100 nM). In contrast, pretreatment of the cells with the antioxidant N-acetyl-cysteine (2 mM) significantly blunted the effect of I/R on Thr308 phosphorylation without affecting Ser473 phosphorylation. Conclusion: In H9c2 cells, I/ R promotes phosphorylation of Akt at both Ser473 and Thr308 in a PI3K-dependent manner. While the phosphorylation of Thr308 (presumably by the action of PDK1, the upstream kinase of Akt) is redox-sensitive, autophosphorylation of Akt at Ser473 appears to be redox-insensitive.
1136-84 Time-Dependent Upregulation of Extracellular Matrix Proteins in Chronic Hibernating Myocardium: Lack of Progressive Degeneration
Vijay S. Iyer, Gen Suzuki, Juliette M. Hardy, Brendan M. Heavey, James A. Fallavollita, John M. Canty, Jr., University at Buffalo, Buffalo, NY, VA Medical Center, Buffalo, NY Background: Biopsies from hibernating myocardium have led to divergent conclusions regarding the role of adaptation vs. degeneration. The latter is inferred from upregulation of ECM proteins that may negatively impact functional recovery. We tested the hypothesis that ECM protein expression is an early event that normalizes in the adapted state. Methods: Swine (n=12) were chronically instrumented with 1.5 mm LAD stenoses to produce hibernating myocardium. RNA was isolated from flash frozen subendocardial tissue and hybridized for cDNA microarray analysis at 3 (n=6) or 5 months (n=6) after instrumentation.
Results: Physiological features of hibernating myocardium were no different at 3 vs 5 months and there was no functional or pathological evidence of progressive deterioration. Subendocardial flow (LAD 0.8 ± 0.1 vs. 1.2 ± 0.1 ml/min/g, p<0.01) and wall thickening (LAD 2.4 ± 0.5 vs. 5.9 ± 0.5 mm, p<0.01) were reduced in comparison with normal regions. Expression of ECM proteins was time dependent (Table) . ECM proteins including collagen, fibronectin, and vimentin were initially upregulated in hibernating LAD regions. After 5 months, the expression of ECM proteins decreased to levels that were similar to normal regions.
Conclusions:
The normalization of ECM genes after 5 months is consistent with the stability of connective tissue demonstrated by pathology. Thus, divergent clinical conclusions regarding adaptation vs. structural degeneration reflect time-dependent alterations in remodeling.
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